Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
[201Tl]Thallium-chlorid 37MBq/ml, til injektion |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
doxorubicinhydrochlorid 10 mg/5 ml injektionsvæske |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
aldesleukin 18 ME pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
natriumdiatrizoat 25 % injektionsvæske, opløsning, ampul |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
natriumdiatrizoat 25 % infusionsvæske, opløsning, flaske |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
natriumdiatrizoat 45 % injektionsvæske, opløsning, ampul |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
diatrizoat 30 % injektionsvæske, opløsning, ampul |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
diatrizoat 58 % injektionsvæske, opløsning, ampul |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
iopamidol 150 mg (I)/ml injektionsvæske, opløsning |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
iopamidol 200 mg (I)/ml injektionsvæske, opløsning |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
iopamidol 300 mg (I)/ml injektionsvæske, opløsning |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
iopamidol 340 mg (I)/ml injektionsvæske, opløsning |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
iopamidol 370 mg(I)/ml injektionsvæske, opløsning |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
iopromid 150 mg(I)/ml infusionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
iopromid 240 mg (I)/ml infusionsvæske, opløsning, flaske |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
iopromid 300 mg(I)/ml infusionsvæske, opløsning |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
iopromid 370 mg (I)/ml infusionsvæske, opløsning, flaske |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
megluminiothalamat 60% infusionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
natriumiothalamat 54% injektionsvæske, opløsning |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
iotrolan 240 mg(I)/ml injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
iotrolan 300 mg(I)/ml injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
ioxaglat 200 mg(I)/ml injektionsvæske, opløsning, ampul |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
ioxaglat 320 mg(I)/ml injektionsvæske, opløsning, ampul |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
megluminiotroxinat 50 mg/ml infusionsvæske, opløsning flaske |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
dimeglumingadopentetat 469,01 mg/ml injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
iohexol 180 mg (I)/ml injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
dimenhydrinat 50 mg/ml injektionsvæske, opløsning, hætteglas a 1 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
opløseligt humant insulin 100 enheder/ml injektionsvæske, opløsning i fyldt pen a 3 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
humant insulin isofan 100 enheder/ml injektionsvæske, suspension i fyldt pen a 3 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
selen 40 µg/ml injektionsvæske, opløsning, hætteglas a 10 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Aminosyrer 6,9 % injektionsvæske, opløsning |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Aminosyrer 8,5 % injektionsvæske, opløsning |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
inamrinon 5 mg/ml injektionsvæske, opløsning, ampul a 20 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
calciumchlorid 13,4%, opløsning til injektion, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
hyoscinhydrobromid 400 µg/ml injektionsvæske, opløsning, ampul |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
hyoscinhydrobromid 600 µg/ml injektionsvæske, opløsning, ampul |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
morphinsulfat 10 mg/1 ml injektion |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
morphinsulfat 15 mg/1ml injektion |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
morphinsulfat 60 mg/2 ml injektion |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
metylenblåt 1 % injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Product containing sodium in parenteral dose form (medicinal product form) |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Fructose-containing product in parenteral dose form |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Intravenøse væsker og elektrolytter |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
metrizoat 100 mg(I)/ml injektionsvæske, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Product containing precisely bleomycin (as bleomycin sulfate) 30 unit/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
technetium[99mTc]-fanolesomab injektionsvæske |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
bacitracin 5.000.000 enheder, pulver til injektionsvæske, opløsning, flaske |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
paracetamol infusionsvæske, opløsning, 1000 mg/100 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
polymælkesyre pulver til injektionsvæske i hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
ampicillin 500 mg + sulbactam 250 mg pulver til injektionsvæske |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
humant immunglobulin 1 g nanofiltreret pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
humant immunglobulin 3 g nanofiltreret pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
humant immunglobulin 6 g nanofiltreret pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
humant immunglobulin 12 g nanofiltreret pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
technetium[99mTc]-depreotid injektionsvæske |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
gentamicin 1,6 mg/ml injektionsvæske, opløsning |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
gentamicin 2,4 mg/ml injektionsvæske, opløsning |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
gentamicin 3,6 mg/ml injektionsvæske, opløsning |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
somatropin (rbe) 5 mg (15 IE)/ml, injektionsvæske, opløsning, cylinderampul a 2 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
epoetin beta 30.000 IE injektionsvæske, opløsning i fyldt injektionssprøjte a 0,6 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
choriogonadotropin alfa 250 µg injektionsvæske, opløsning, 0,5 ml i fyldt injektionssprøjte |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
follitropin alfa 300 IE injektionsvæske, opløsning i fyldt pen a 0,5 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
follitropin alfa 450 IE injektionsvæske, opløsning i fyldt pen a 0,75 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
follitropin alfa 900 IE injektionsvæske, opløsning i fyldt pen a 1,5 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Pegvisomant 15 mg powder for solution for injection vial |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
darbepoetin alfa 500 µg injektionsvæske, opløsning i fyldt injektionssprøjte a 1 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
technetium[99mTc]-arcitumomab injektionsvæske |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
pentetatcalciumtrinatrium 200 mg/ml injektionsvæske, opløsning, 5 ml ampul |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
pentetatzinktrinatrium 200 mg/ml injektionsvæske, opløsning, 5 ml ampul |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
rekombinant koagulationsfaktor IX 250 IE, pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
rekombinant koagulationsfaktor IX 500 IE, pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
rekombinant koagulationsfaktor IX 1000 IE, pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
faktor IX-koncentrat 500 IE, pulver til injektionsvæske, opløsning, hætteglas a 10 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
faktor IX-koncentrat 1000 IE, pulver til injektionsvæske, opløsning, hætteglas a 20 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Pentastivelse 6 % i natriumchlorid 7,2 % infusionsvæske, opløsning |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
natriumglycerophosphat 4,32 g injektionsvæske, opløsning, hætteglas a 20 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
chloroquinsulfat 272,5 mg/5 ml injektionsvæske, opløsning |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Chlorothiazide 500 mg powder for solution for injection vial |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
hyaluronidase 150 enheder/ml injektionsvæske, opløsning, hætteglas a 2 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Agalsidase beta 5 mg powder for solution for injection vial |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
difteri-/tetanus-/inaktiveret poliovaccine, i fyldt injektionssprøjte a 0,5 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
difteri-/tetanus-/kighoste-/inaktiveret poliovaccine, i fyldt injektionssprøjte a 0,5 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
difteri-/tetanus-/kighoste-/polio-/Haemophilus influenzae type B-vaccine hætteglas a 0,5 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
glatirameracetat 20 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 1 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
dinatriumpamidronat 3 mg/ml injektionsvæske, opløsning, hætteglas a 20 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
dinatriumpamidronat 3 mg/ml injektionsvæske, opløsning, hætteglas a 30 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
cosyntropin 25 µg + mannitol 10 mg injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
clonidinhydrochlorid 0,5 mg/ml injektionsvæske, opløsning, hætteglas a 10 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Ethacrynate sodium 50 mg powder for solution for injection vial |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
hylan B gelimplantat med store partikler 5,5 mg/ml til injektion, fyldt sprøjte |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
benzquinamid 50 mg injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
gadobenatdimeglumin 529 mg/ml injektionsvæske, opløsning |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
natalizumab 300 mg injektionsvæske, opløsning, hætteglas a 15 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
natriumhyaluronat 1,2 % injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
natriumhyaluronat 1,2 % injektionsvæske, opløsning i fyldt injektionssprøjte a 0,8 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
natriumhyaluronat 3 % injektionsvæske, opløsning i fyldt injektionssprøjte a 0,6 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
natriumhyaluronat 10 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,4 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
hydroxypropylmethylcellulose 2 % injektionsvæske, opløsning i fyldt injektionssprøjte a 1 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
natriumhyaluronat 1,6 % injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
natriumhyaluronat 1,6 % injektionsvæske, opløsning i fyldt injektionssprøjte a 0,8 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
natriumhyaluronat 10 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|